Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II,Multicenter,Randomized,Double-blind,Cross-over Study of Palonosetron Compared With Granisetron in Prevention of Chemotherapy-induced Nausea and Vomiting in Asian Population

NCT00503386 is registered in ClinicalTrials.gov with Hangzhou Jiuyuan Gene Engineering Co. Ltd., as lead sponsor.

NCT NCT00503386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00503386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II,Multicenter,Randomized,Double-blind,Cross-over Study of Palonosetron Compared With Granisetron in Prevention of Chemotherapy-induced Nausea and Vomiting in Asian Population
Lead sponsor
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2006
Completion date
October 31, 2006
Enrollment
144 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, nausea, vomiting